Company Filing History:
Years Active: 2014-2015
Title: Chungsun Chien: Innovator in Nucleoside Synthesis
Introduction
Chungsun Chien is a notable inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of nucleoside synthesis, holding a total of 2 patents. His work focuses on innovative processes that enhance the synthesis of nucleoside compounds.
Latest Patents
Chien's latest patents include a process for the synthesis of 5-deoxy-5'-fluorocytidine compounds. This invention relates to a method of synthesizing a β-nucleoside compound, where R can be alkyl, aryl, cycloalkyl, heteroaryl, or heterocycloalkyl. The process involves reacting a compound with a specific formula in a solvent and in the presence of a base. Another significant patent describes a process for stereoselectively synthesizing β-nucleosides, such as 2'-deoxy-2,2′-difluorocytidine. This method includes reacting a tetrahydrofuran compound with a nucleobase derivative in the presence of an oxidizing agent.
Career Highlights
Chungsun Chien is currently associated with Pharmaessentia Corporation, where he continues to advance his research in nucleoside synthesis. His innovative approaches have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Chien has collaborated with notable colleagues, including Ko-Chung Lin and Pin-Shu Chien. These partnerships have contributed to the development of his patented processes and have fostered a collaborative environment for innovation.
Conclusion
Chungsun Chien's contributions to nucleoside synthesis through his patents reflect his dedication to advancing pharmaceutical science. His work continues to influence the field and showcases the importance of innovation in developing new compounds.